Log in
Enquire now
Emmanuelle Charpentier

Emmanuelle Charpentier

French chemist, scientist & biochemist, founder of CRISPR Therapeutics & ERS Genomics, based in France

OverviewStructured DataIssuesContributors

Contents

emmanuelle-charpentier-lab.org
mpg.de/9343753/infektionsbiologie-charpentier
emmanuelle-charpentier-pr.org
Is a
Person
Person

Person attributes

Founder of
ERS Genomics
ERS Genomics
CRISPR Therapeutics
CRISPR Therapeutics
Birthdate
December 11, 1968
Birthplace
Juvisy-sur-Orge
Juvisy-sur-Orge
Nationality
Location
France
France
Educated at
Pasteur Institute
Pasteur Institute
Pierre and Marie Curie University
Pierre and Marie Curie University
Awards Received
‌
2015 Princess of Asturias Award
‌
2015 Breakthrough Prize in Life Sciences
‌
2015 Louis-Jeantet Prize for Medicine
‌
2016 Canada Gairdner International Award
‌
2016 Leibniz Prize
‌
2017 Pour le Mérite
‌
2017 The Novozymes Prize
‌
2020 Wolf Prize in Medicine
...
Occupation
‌
Biochemist
Geneticist
Geneticist
Microbiologist
Microbiologist
Chemist
Chemist
‌
Biologist
Scientist
Scientist
ORCID
0000-0002-0254-07780

Other attributes

Blog
forbes.com/profile/e...arpentier/
Citizenship
France
France
Known for
CRISPR
Wikidata ID
Q17280087
No article content yet.

Timeline

No Timeline data yet.

Current Employer

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more people like Emmanuelle Charpentier

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.